200 related articles for article (PubMed ID: 37649603)
1. Erythroid-transdifferentiated myeloid cells promote portal vein tumor thrombus in hepatocellular carcinoma.
Zhu WH; Chen J; Huang RK; Zhang Y; Huang ZX; Pang XQ; Hu B; Yang Y; Li X
Theranostics; 2023; 13(13):4316-4332. PubMed ID: 37649603
[No Abstract] [Full Text] [Related]
2. Intratumoral CD45
Chen J; Qiao YD; Li X; Xu JL; Ye QJ; Jiang N; Zhang H; Wu XY
Cancer Lett; 2021 Feb; 499():85-98. PubMed ID: 33279623
[TBL] [Abstract][Full Text] [Related]
3. miR-517b-3p promotes the progression of portal vein tumor thrombus via activating Wnt/β-catenin signaling pathway in hepatocellular carcinoma.
Ke RS; Huang KZ; Bao DS; Yang JR; Wang HX; Lv LZ; Jiang Y; Liu ZH; Zhang FX
Mol Biol Rep; 2022 Aug; 49(8):7793-7805. PubMed ID: 35666423
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma.
Liu S; Guo W; Shi J; Li N; Yu X; Xue J; Fu X; Chu K; Lu C; Zhao J; Xie D; Wu M; Cheng S; Liu S
J Hepatol; 2012 Feb; 56(2):389-96. PubMed ID: 21888875
[TBL] [Abstract][Full Text] [Related]
5. Identification of prognostic biomarkers associated with the occurrence of portal vein tumor thrombus in hepatocellular carcinoma.
Lin T; Lin Z; Mai P; Zhang E; Peng L
Aging (Albany NY); 2021 Apr; 13(8):11786-11807. PubMed ID: 33878734
[TBL] [Abstract][Full Text] [Related]
6. Modulation of chemotactic and pro-inflammatory activities of endothelial progenitor cells by hepatocellular carcinoma.
Shih YT; Wang MC; Peng HH; Chen TF; Chen L; Chang JY; Chiu JJ
Cell Signal; 2012 Mar; 24(3):779-93. PubMed ID: 22120522
[TBL] [Abstract][Full Text] [Related]
7. Endothelial precursor cells promote angiogenesis in hepatocellular carcinoma.
Sun XT; Yuan XW; Zhu HT; Deng ZM; Yu DC; Zhou X; Ding YT
World J Gastroenterol; 2012 Sep; 18(35):4925-33. PubMed ID: 23002366
[TBL] [Abstract][Full Text] [Related]
8. Progress on the molecular mechanism of portal vein tumor thrombosis formation in hepatocellular carcinoma.
Zhang M; Ding Q; Bian C; Su J; Xin Y; Jiang X
Exp Cell Res; 2023 May; 426(1):113563. PubMed ID: 36944406
[TBL] [Abstract][Full Text] [Related]
9. EphA1 activation promotes the homing of endothelial progenitor cells to hepatocellular carcinoma for tumor neovascularization through the SDF-1/CXCR4 signaling pathway.
Wang Y; Yu H; Shan Y; Tao C; Wu F; Yu Z; Guo P; Huang J; Li J; Zhu Q; Yu F; Song Q; Shi H; Zhou M; Chen G
J Exp Clin Cancer Res; 2016 Apr; 35():65. PubMed ID: 27066828
[TBL] [Abstract][Full Text] [Related]
10. Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus.
Zhou J; Tang ZY; Fan J; Wu ZQ; Li XM; Liu YK; Liu F; Sun HC; Ye SL
J Cancer Res Clin Oncol; 2000 Jan; 126(1):57-61. PubMed ID: 10641751
[TBL] [Abstract][Full Text] [Related]
11. S100P as a novel biomarker of microvascular invasion and portal vein tumor thrombus in hepatocellular carcinoma.
Qi LN; Ma L; Wu FX; Chen YY; Xing WT; Jiang ZJ; Zhong JH; Chen ZS; Gong WF; Ye JZ; Li HH; Shang JJ; Xiang BD; Li LQ
Hepatol Int; 2021 Feb; 15(1):114-126. PubMed ID: 33495903
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of portal vein tumour thrombus formation and development in patients with hepatocellular carcinoma.
Li Z; Zhao M; Qi X; Tang Y; Cheng S
J Cell Mol Med; 2023 Aug; 27(15):2103-2111. PubMed ID: 37349905
[TBL] [Abstract][Full Text] [Related]
13. Identification of two portal vein tumor thrombosis associated proteins in hepatocellular carcinoma: protein disulfide-isomerase A6 and apolipoprotein A-I.
Xu X; Wei X; Ling Q; Cheng J; Zhou B; Xie H; Zhou L; Zheng S
J Gastroenterol Hepatol; 2011 Dec; 26(12):1787-94. PubMed ID: 21649721
[TBL] [Abstract][Full Text] [Related]
14. CD45
Wen JY; Li X; Chen JN; Chen J; Zhang JY; Du Y; Zhu WH; Chen YJ; Yang RH; Shao CK
Gastric Cancer; 2023 Nov; 26(6):918-933. PubMed ID: 37676622
[TBL] [Abstract][Full Text] [Related]
15. A new and rare type of hepatocellular carcinoma: Survival and gene analysis of portal vein tumour thrombus-type hepatocellular carcinoma.
Guo WX; Yang SY; Guo L; Feng JK; Xue J; Shi J; Lau WY; Yu D; Cheng SQ
Pathol Res Pract; 2023 Jan; 241():154260. PubMed ID: 36509007
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of hepatocellular carcinoma in China: surgical techniques, indications, and outcomes.
Chen XP; Huang ZY
Langenbecks Arch Surg; 2005 Jun; 390(3):259-65. PubMed ID: 15875211
[TBL] [Abstract][Full Text] [Related]
17. LAG3
Pang XQ; Li X; Zhu WH; Huang RK; Mo ZS; Huang ZX; Zhang Y; Xie DY; Gao ZL
Antiviral Res; 2023 May; 213():105592. PubMed ID: 37004734
[TBL] [Abstract][Full Text] [Related]
18. Six2 is negatively correlated with prognosis and facilitates epithelial-mesenchymal transition via TGF-β/Smad signal pathway in hepatocellular carcinoma.
Wan ZH; Ma YH; Jiang TY; Lin YK; Shi YY; Tan YX; Dong LW; Wang HY
Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):525-531. PubMed ID: 31564506
[TBL] [Abstract][Full Text] [Related]
19. An Eastern Hepatobiliary Surgery Hospital/Portal Vein Tumor Thrombus Scoring System as an Aid to Decision Making on Hepatectomy for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus: A Multicenter Study.
Zhang XP; Gao YZ; Chen ZH; Chen MS; Li LQ; Wen TF; Xu L; Wang K; Chai ZT; Guo WX; Shi J; Xie D; Wu MC; Yee Lau W; Cheng SQ
Hepatology; 2019 May; 69(5):2076-2090. PubMed ID: 30586158
[TBL] [Abstract][Full Text] [Related]
20. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.
Spreafico C; Sposito C; Vaiani M; Cascella T; Bhoori S; Morosi C; Lanocita R; Romito R; Chiesa C; Maccauro M; Marchianò A; Mazzaferro V
J Hepatol; 2018 Apr; 68(4):724-732. PubMed ID: 29331342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
